In this retrospective analysis of a large database, researchers found that patients recently discharged after an MI or stent on PPI-clopidogrel had a 93% higher risk of re-hospitalization for MI (and 64% higher risk for re-hospitalization for MI or stent) than patients on clopidogrel without a PPI. This association was found despite type of PPI (omeprazole or pantoprazole). The current warning on PPI labeling, to avoid concomitant use with clopidogreal when able, is probably warranted, until the controversy can be resolved (abstract)
Categories
Related Posts
What comes to mind when you think of getting CME? I bet most of you would say sitting in an auditorium, whether that be during your local grand rounds or at our professional society meeting, like Hospital Medicine 16 in sunny San Diego this past March. Hanging out in the Twitterverse? Probably not so much… […]
As a nurse practitioner in hospital medicine I have multiple opportunities to interact with all sorts of physician hospitalist colleagues, hospital medicine group leaders, quality officers etc. Often their interactions with me take on a certain wary curiosity, like I am some exotic monkey or another creature that is unfamiliar to them. If I am […]
By reading the headlines recently, practitioners would not know if they saved or tanked the healthcare system. One day disaster looms, the next we have moderated growth and business can continue as usual (and by business, I mean doing the correct things correctly). A new study, along with some recent data, helps shed some light […]
Leave A Comment